1. Home
  2. BCRX vs WD Comparison

BCRX vs WD Comparison

Compare BCRX & WD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$9.52

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Walker & Dunlop Inc

WD

Walker & Dunlop Inc

HOLD

Current Price

$44.38

Market Cap

2.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCRX
WD
Founded
1986
1937
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.1B
IPO Year
1995
2010

Fundamental Metrics

Financial Performance
Metric
BCRX
WD
Price
$9.52
$44.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
3
Target Price
$20.82
$78.33
AVG Volume (30 Days)
5.9M
386.5K
Earning Date
05-04-2026
04-30-2026
Dividend Yield
N/A
6.25%
EPS Growth
381.40
N/A
EPS
1.21
1.64
Revenue
$25,186,000.00
$1,234,306,000.00
Revenue This Year
N/A
$20.60
Revenue Next Year
$12.55
$7.79
P/E Ratio
$7.83
$26.51
Revenue Growth
N/A
8.99
52 Week Low
$6.00
$42.12
52 Week High
$11.31
$90.00

Technical Indicators

Market Signals
Indicator
BCRX
WD
Relative Strength Index (RSI) 64.59 36.15
Support Level $7.85 $42.12
Resistance Level $10.32 $66.25
Average True Range (ATR) 0.60 1.65
MACD -0.03 0.41
Stochastic Oscillator 65.44 30.62

Price Performance

Historical Comparison
BCRX
WD

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About WD Walker & Dunlop Inc

Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.

Share on Social Networks: